PDF icon Download PDF
J Reconstr Microsurg
DOI: 10.1055/a-2555-2252
Original Article

Optimizing Postoperative Anticoagulation Regimen to Improve Lower Extremity Free Flap Outcomes

Kylie R. Swiekatowski 
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
Delani E. Woods
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
Ellen B. Wang
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
Edwin Acevedo Jr.
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
David C. Hopkins
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
Mohin A. Bhadkamkar
1   Division of Plastic Surgery, Department of Surgery, McGovern Medical School at the University of Texas Health at Houston, Houston, Texas
,
Yuewei Wu-Fienberg 
2   Department of Plastic Surgery, Kaiser Permanente Woodland Hills Medical Center, Woodland Hills, California
› Author Affiliations
Funding None.
› Further Information
Also available atMedOne
   Permissions and Reprints
Preview

Abstract

Background

Free flap reconstruction for lower extremity (LE) trauma has a higher failure rate than free flaps in other anatomic regions. Postoperative anticoagulation and antiplatelet therapy may influence LE free flap outcomes, but an optimal regimen has not been established. This study aims to evaluate complication rates associated with different anticoagulation and antiplatelet protocols in LE free flap reconstruction.

Methods

Adult patients (≥18 years of age) with LE trauma requiring free flap reconstruction at our level 1 trauma center from 2016 to 2021 were included for retrospective chart review. Complications requiring reoperation were grouped into a composite variable named major complications (i.e., hematoma, flap thrombosis, flap necrosis >10%, infection requiring reoperation). Nonrandomized patients were categorized into three groups based on postoperative anticoagulation or antiplatelet regimen (aspirin only, heparin only, and aspirin + heparin), with heparin being a subtherapeutic fixed-dose heparin infusion at 500 to 800 units/hour. Complication rates were compared across groups, and both univariate and multivariate analyses were conducted to identify associations with major complications. p-Values were set at p < 0.05.

Results

Of 191 patients, 37 (19.4%) received aspirin only, 76 (39.8%) received heparin only, and 78 (40.8%) received aspirin + heparin. Demographics were similar between the groups. On univariate analysis, the heparin group had a significantly lower rate of major complications (5.26%) compared with aspirin only (18.92%) and aspirin + heparin (20.51%; p = 0.016); however, on multivariate analysis, when accounting for additional perioperative factors, no association between anticoagulation group and major complications was found.

Conclusion

Our study found that neither aspirin alone, heparin alone, or aspirin + heparin demonstrated a more favorable association with LE free flap outcomes. To reduce bias from the study's retrospective design and the surgeon's discretion in choosing anticoagulation protocols, future research should randomize patients to standardized postoperative regimens to assess differences in complications.

Keywords

free flap reconstruction - anticoagulation - lower extremity


Publication History

Received: 01 October 2024

Accepted: 19 February 2025

Accepted Manuscript online:
11 March 2025

Article published online:
22 May 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA